Resultados de búsqueda - (over OR omar)*

  1. 401
  2. 402
  3. 403
  4. 404
  5. 405
  6. 406
  7. 407
  8. 408
  9. 409
  10. 410
  11. 411
  12. 412
  13. 413
  14. 414

    Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective analysis por Pérez Alba, Eduardo, Nuzzolo Shihadeh, Laura Marina, Aguirre García, Gloria Mayela, Espinosa Mora, Jaime Eugenio, Lecona García, Juan Diego, Flores Pérez, Rómulo Omar, Mendoza Garza, Marisela, Camacho Ortiz, Adrián

    Publicado 2021
    “…Our primary objective was to compare overall mortality and secondly to compare progression to mechanical ventilation and over infection rates. Results: A total of 793 patients were assessed for inclusion criteria, 596 were excluded and 197 were analyzed for primary outcome: 123 in the baricitinib plus dexamethasone group and 74 in the dexamethasone monotherapy group. …”
    Enlace del recurso
    Artículo
  15. 415
  16. 416
  17. 417
  18. 418
  19. 419
  20. 420

Herramientas de búsqueda: